A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

10.1186/s12885-020-07616-4

Saved in:
Bibliographic Details
Main Authors: Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: BioMed Central Ltd 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/199287
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-199287
record_format dspace
spelling sg-nus-scholar.10635-1992872024-04-24T05:49:40Z A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours Ang, Y.L.E. Ho, G.F. Soo, R.A. Sundar, R. Tan, S.H. Yong, W.P. Ow, S.G.W. Lim, J.S.J. Chong, W.Q. Soe, P.P. Tai, B.C. Wang, L. Goh, B.C. Lee, S.-C. CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Advanced solid tumours Anti-angiogenic Docetaxel Short-course sunitinib Tumour vasculature 10.1186/s12885-020-07616-4 BMC Cancer 20 1 1118 2021-08-25T14:04:41Z 2021-08-25T14:04:41Z 2020 Article Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C. (2020). A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC Cancer 20 (1) : 1118. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-020-07616-4 14712407 https://scholarbank.nus.edu.sg/handle/10635/199287 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd Scopus OA2020
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Advanced solid tumours
Anti-angiogenic
Docetaxel
Short-course sunitinib
Tumour vasculature
spellingShingle Advanced solid tumours
Anti-angiogenic
Docetaxel
Short-course sunitinib
Tumour vasculature
Ang, Y.L.E.
Ho, G.F.
Soo, R.A.
Sundar, R.
Tan, S.H.
Yong, W.P.
Ow, S.G.W.
Lim, J.S.J.
Chong, W.Q.
Soe, P.P.
Tai, B.C.
Wang, L.
Goh, B.C.
Lee, S.-C.
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
description 10.1186/s12885-020-07616-4
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Ang, Y.L.E.
Ho, G.F.
Soo, R.A.
Sundar, R.
Tan, S.H.
Yong, W.P.
Ow, S.G.W.
Lim, J.S.J.
Chong, W.Q.
Soe, P.P.
Tai, B.C.
Wang, L.
Goh, B.C.
Lee, S.-C.
format Article
author Ang, Y.L.E.
Ho, G.F.
Soo, R.A.
Sundar, R.
Tan, S.H.
Yong, W.P.
Ow, S.G.W.
Lim, J.S.J.
Chong, W.Q.
Soe, P.P.
Tai, B.C.
Wang, L.
Goh, B.C.
Lee, S.-C.
author_sort Ang, Y.L.E.
title A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
title_short A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
title_full A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
title_fullStr A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
title_full_unstemmed A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
title_sort randomized phase ii trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
publisher BioMed Central Ltd
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/199287
_version_ 1800914980206280704